Prospective Clinico-biological Database of Patients With Ovarian and/or Peritoneal and/or Fallopian Tube Carcinoma

Launched by CENTRE OSCAR LAMBRET · May 9, 2025

Keywords

ClinConnect Summary

This clinical trial is focused on understanding and improving the outcomes for women diagnosed with advanced ovarian cancer, peritoneal cancer, or fallopian tube cancer. The goal is to gather important information about the patients and their tumors to help predict how long they might live after starting treatment. This study will collect data from 371 women over five years at the Oscar Lambret Center, creating a comprehensive database that combines details about both the patients and their cancer.

To be eligible for this trial, participants must be women aged 18 or older who have been diagnosed with advanced cancer of the ovary, peritoneum, or fallopian tube, and they need to provide consent to join. Once enrolled, participants will be involved in the study for two years, during which they will receive standard care and allow researchers to collect information about their treatments and health outcomes. It’s important to note that this trial is not yet recruiting patients, and those who are currently under legal guardianship or choose not to participate will not be included.

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • Patient aged 18 or over
• • Informed consent warranted
• • Patient affiliated to a social security regimen
• • Suspected or confirmed diagnosis of advanced and invasive ovarian cancer and/or primary peritoneal cancer and/or fallopian tube cancer (IIB to IV FIGO stages)
• • Inclusion during standard care at the Oscar Lambret Centre, from diagnosis to the day of surgery
• Exclusion Criteria:
• • Patient deprived of liberty or under curatorship or guardianship
• • Refusal to participate